Researchers at UNIGE and HUG have created CAR-T cells that can selectively target malignant gliomas, sparing the surrounding healthy tissue. Glioblastoma is the most common and aggressive form of ...
Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which current treatments remain ineffective. In ...
for treating brain tumors called IDH-mutant low-grade gliomas (LGGs). Their research raises significant concerns about the approval process and the drug's actual benefits for patients. LGGs are a ...